TY - JOUR AU - Bower, P. AU - Byford, S. AU - Barber, J. AU - Beecham, J. AU - Simpson, S. AU - Friedli, K. AU - Corney, R. AU - King, M. AU - Harvey, I. PY - 2003 DA - 2003// TI - Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses JO - BMJ VL - 326 UR - https://doi.org/10.1136/bmj.326.7401.1247 DO - 10.1136/bmj.326.7401.1247 ID - Bower2003 ER - TY - JOUR AU - Byford, S. AU - Knapp, M. AU - Greenshields, J. AU - Ukoumunne, O. AU - Jones, V. AU - Thompson, S. AU - Tyrer, P. AU - Schmidt, U. AU - Davidson, K. AU - Group, P. PY - 2003 DA - 2003// TI - Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach JO - Psychol Med VL - 33 UR - https://doi.org/10.1017/S0033291703008183 DO - 10.1017/S0033291703008183 ID - Byford2003 ER - TY - JOUR AU - Chilcott, J. AU - McCabe, C. AU - Tappenden, P. AU - O'Hagan, A. AU - Cooper, N. AU - Abrams, K. AU - Claxton, K. AU - Miller, D. AU - Group, C. E. o. M. S. T. S. PY - 2003 DA - 2003// TI - Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in mulitple sclerosis JO - BMJ VL - 326 UR - https://doi.org/10.1136/bmj.326.7388.522 DO - 10.1136/bmj.326.7388.522 ID - Chilcott2003 ER - TY - JOUR AU - Delaney, B. AU - Wilson, S. AU - Roalfe, A. AU - Roberts, L. AU - Redman, V. AU - Wearn, A. AU - Briggs, A. AU - Hobbs, F. PY - 2000 DA - 2000// TI - Cost effectiveness of initial endoscopy for dypepsia in patients over age 50 years: a randomised controlled trial in primary care JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)03308-0 DO - 10.1016/S0140-6736(00)03308-0 ID - Delaney2000 ER - TY - JOUR AU - Drummond, M. AU - Becker, D. AU - Hux, M. AU - Chancellor, J. AU - Duprat-Lomon, I. AU - Kubin, R. AU - Sagnier, P. PY - 2003 DA - 2003// TI - An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia JO - Chest VL - 124 UR - https://doi.org/10.1378/chest.124.2.526 DO - 10.1378/chest.124.2.526 ID - Drummond2003 ER - TY - JOUR AU - Gray, A. AU - Raikou, M. AU - McGuire, A. AU - Fenn, P. AU - Stevens, R. AU - Cull, C. AU - Stratton, I. AU - Adler, A. AU - Holman, R. AU - Turner, R. PY - 2000 DA - 2000// TI - Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) JO - BMJ VL - 320 UR - https://doi.org/10.1136/bmj.320.7246.1373 DO - 10.1136/bmj.320.7246.1373 ID - Gray2000 ER - TY - JOUR AU - Manns, B. AU - Lee, H. AU - Doig, C. AU - Johnson, D. AU - Donaldson, C. PY - 2002 DA - 2002// TI - An economic evaluation of activated protein C treatment for severe sepsis JO - New England Journal of Medicine VL - 347 UR - https://doi.org/10.1056/NEJMsa020969 DO - 10.1056/NEJMsa020969 ID - Manns2002 ER - TY - JOUR PY - 2002 DA - 2002// TI - Multicentre aneurysm screening study (MASS):cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from a randomised controlled trial JO - BMJ VL - 325 UR - https://doi.org/10.1136/bmj.325.7373.1135 DO - 10.1136/bmj.325.7373.1135 ID - ref8 ER - TY - JOUR AU - Ramsey, S. AU - Berry, K. AU - Etzioni, R. AU - Kaplan, R. AU - Sullivan, S. AU - Wood, D. PY - 2003 DA - 2003// TI - Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema JO - New England Journal of Medicine VL - 348 UR - https://doi.org/10.1056/NEJMsa030448 DO - 10.1056/NEJMsa030448 ID - Ramsey2003 ER - TY - JOUR AU - Sheldon, R. AU - O'Brien, B. AU - Blackhouse, G. AU - Goeree, R. AU - Mitchell, B. AU - Klein, G. AU - Roberts, R. AU - Gent, M. AU - Connolly, S. PY - 2001 DA - 2001// TI - Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study JO - Circulation VL - 104 UR - https://doi.org/10.1161/hc3901.096720 DO - 10.1161/hc3901.096720 ID - Sheldon2001 ER - TY - JOUR PY - 1998 DA - 1998// TI - Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 JO - BMJ VL - 317 UR - https://doi.org/10.1136/bmj.317.7160.720 DO - 10.1136/bmj.317.7160.720 ID - ref11 ER - TY - JOUR AU - Marshall, D. AU - Levy, A. AU - Vidaillet, H. AU - Fenwick, E. AU - Slee, A. AU - Blackhouse, G. AU - Greene, H. AU - Wyse, G. AU - Nichol, G. AU - O'Brien, B. PY - 2004 DA - 2004// TI - Cost-effectiveness of rhythm versus rate control in atrial fibrillation JO - Annals of Internal Medicine VL - 141 UR - https://doi.org/10.7326/0003-4819-141-9-200411020-00005 DO - 10.7326/0003-4819-141-9-200411020-00005 ID - Marshall2004 ER - TY - JOUR AU - Fenwick, E. AU - Claxton, K. AU - Sculpher, M. PY - 2001 DA - 2001// TI - Representing uncertainty: The role of cost-effectiveness acceptability curves JO - Health Econ VL - 10 UR - https://doi.org/10.1002/hec.635 DO - 10.1002/hec.635 ID - Fenwick2001 ER - TY - JOUR AU - Wyse, G. AU - Waldo, A. AU - DiMarco, J. AU - Domanski, M. AU - Rosenberg, Y. AU - Schron, E. PY - 2002 DA - 2002// TI - A comparison of rate control and rhythm control in patients with atrial fibrillation JO - New England Journal of Medicine VL - 347 UR - https://doi.org/10.1056/NEJMoa021328 DO - 10.1056/NEJMoa021328 ID - Wyse2002 ER - TY - JOUR AU - Black, W. PY - 1990 DA - 1990// TI - The CE plane: A graphic representation of cost-effectiveness JO - Medical Decision Making VL - 10 UR - https://doi.org/10.1177/0272989X9001000308 DO - 10.1177/0272989X9001000308 ID - Black1990 ER - TY - JOUR AU - Stinnett, A. A. AU - Mullahy, J. PY - 1998 DA - 1998// TI - Net Health Benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis JO - Med Decis Making VL - 18 UR - https://doi.org/10.1177/0272989X98018002S09 DO - 10.1177/0272989X98018002S09 ID - Stinnett1998 ER - TY - CHAP AU - Briggs, A. H. AU - Gray, A. PY - 1999 DA - 1999// TI - Handling uncertainty when performing economic evaluation of healthcare interventions BT - Health Tech Assess ID - Briggs1999 ER - TY - JOUR AU - Briggs, A. H. AU - Wonderling, D. E. AU - Mooney, C. Z. PY - 1997 DA - 1997// TI - Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation JO - Health Economics VL - 6 UR - https://doi.org/3.0.CO;2-W DO - 3.0.CO;2-W ID - Briggs1997 ER - TY - JOUR AU - Lothgren, M. AU - Zethraeus, N. PY - 2000 DA - 2000// TI - Definition, interpretation and calculation of cost-effectiveness acceptability curves JO - Health Economics VL - 9 UR - https://doi.org/3.0.CO;2-V DO - 3.0.CO;2-V ID - Lothgren2000 ER - TY - JOUR AU - Willan, A. AU - O'Brien, B. PY - 1996 DA - 1996// TI - Confidence intervals for cost-effectiveness analysis ratios: an application of Fieller's theorem JO - Health Economics VL - 5 UR - https://doi.org/3.0.CO;2-T DO - 3.0.CO;2-T ID - Willan1996 ER - TY - JOUR AU - Heitjan, D. F. AU - Moskowitz, A. J. AU - Whang, W. PY - 1999 DA - 1999// TI - Problems with interval estimates of the incremental cost-effectiveness ratio JO - Medical Decision Making VL - 19 UR - https://doi.org/10.1177/0272989X9901900102 DO - 10.1177/0272989X9901900102 ID - Heitjan1999 ER - TY - JOUR AU - O'Hagan, A. AU - Stevens, J. W. AU - Montmartin, J. PY - 2000 DA - 2000// TI - Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio JO - Pharmacoeconomics VL - 17 UR - https://doi.org/10.2165/00019053-200017040-00004 DO - 10.2165/00019053-200017040-00004 ID - O'Hagan2000 ER - TY - JOUR AU - Briggs, A. AU - Fenn, P. PY - 1998 DA - 1998// TI - Confidence intervals or surfaces ? Uncertainty on the cost-effectiveness plane JO - Health Economics VL - 7 UR - https://doi.org/3.0.CO;2-O DO - 3.0.CO;2-O ID - Briggs1998 ER - TY - JOUR AU - Van Hout, B. AU - Al, M. AU - Gordon, G. AU - Rutten, F. PY - 1994 DA - 1994// TI - Costs, effects and c/e-ratios alongside a clinical trial JO - Health Economics VL - 3 UR - https://doi.org/10.1002/hec.4730030505 DO - 10.1002/hec.4730030505 ID - Van Hout1994 ER - TY - JOUR AU - O'Brien, B. AU - Briggs, A. PY - 2002 DA - 2002// TI - Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods JO - Statistical Methods in Medical Research VL - 11 UR - https://doi.org/10.1191/0962280202sm304ra DO - 10.1191/0962280202sm304ra ID - O'Brien2002 ER - TY - JOUR AU - Fenwick, E. AU - O'Brien, B. AU - Briggs, A. PY - 2004 DA - 2004// TI - Cost-effectiveness acceptability curves: facts, fallacies and frequently asked questions JO - Health Economics VL - 13 UR - https://doi.org/10.1002/hec.903 DO - 10.1002/hec.903 ID - Fenwick2004 ER - TY - JOUR AU - Bahnson, T. D. AU - Grant, A. O. PY - 2004 DA - 2004// TI - To be or not to be in normal sinus rhythm: What do we really know? JO - Annals of Internal Medicine VL - 141 UR - https://doi.org/10.7326/0003-4819-141-9-200411020-00016 DO - 10.7326/0003-4819-141-9-200411020-00016 ID - Bahnson2004 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/6/52/prepub UR - http://www.biomedcentral.com/1472-6963/6/52/prepub ID - ref28 ER -